Last $27.43 USD
Change Today +0.2293 / 0.84%
Volume 222.2K
KITE On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 10:44 AM 08/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arie S. Belldegrun M.D., FACS

Founder, Executive Chairman, Chief Executive Officer and President, Kite Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 59 board members in 6 different organizations across 10 different industries.

See Board Relationships
65$572,607
As of Fiscal Year 2013

Background*

Dr. Arie S. Belldegrun, M.D., FACS founded Kite Pharma, Inc. in 2009 and has been its Chief Executive Officer and President since April 2, 2014. Dr. Belldegrun served as Partner at Two River Group Holdings LLC. He serves as the Chief of Division of Urological Oncology. He serves as a Professor and holds the Carol and Roy Doumani Chair in Urologic Oncology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) since 1996, whose faculty ...

Read Full Background

Corporate Headquarters*

2225 Colorado Avenue
Santa Monica, California 90404

United States

Phone: 310-824-9999
Fax: --

Board Members Memberships*

Founder and Chairman
Former Director
Partner, Chairman, and a Member of Advisory Board
Chairman
2003-2009
Chairman of Scientific Advisory Board
2004-2009
Former Director, Chairman of Compensation Committee and Member of Nominating & Governance Committee
2005-2008
Former Director
2008-Present
Non-Executive Chairman
2009-Present
Director
2009-N/A
Director
2009-Present
Founder, Executive Chairman, Chief Executive Officer and President
2013-Present
Director and Chairman of Science & Technology Committee

Education*

BS
Hebrew University Faculty of Medicine
MD
Hebrew University Faculty of Medicine

Other Affiliations*

Annual Compensation*

Salary$16,667
Total Annual Compensation$16,667

Stock Options*

All Other Compensation$27,687
Unexercisable Options800,000
Total Number of Options800,000

Total Compensation*

Total Annual Cash Compensation$188,104
Total Short Term Compensation$16,667
Other Long Term Compensation$27,687
Total Calculated Compensation$572,607
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KITE:US $27.40 USD +0.20

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KITE PHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.